MARKET SURGERY — All Prescriptions & Medications
Practice Code: D82016 | NORWICH, NR11 6BW
Over the last 12 months, MARKET SURGERY prescribed 285,691 items across 629 different medications at a total cost of £2,000,521 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Diltiazem hydrochloride | 10 | 360 | £261 | +115.9% ▲ |
| Formoterol fumarate | 10 | 12 | £341 | -30.3% ▼ |
| Desloratadine | 10 | 300 | £26 | -65.3% ▼ |
| Denosumab | 10 | 10 | £1.6K | -63.3% ▼ |
| Oral rehydration salts | 10 | 366 | £151 | -65.4% ▼ |
| Powder extensively hydrolysed formula with MCT (0913102) | 10 | 19.4K | £720 | +79.1% ▲ |
| Tablets/capsules micronutrient supplement (0913282) | 10 | 360 | £253 | -4.5% ▼ |
| Powder micronutrient supplement (0913291) | 10 | 8,000 | £1.0K | +25.8% ▲ |
| Prednisolone acetate | 10 | 90 | £30 | -45.1% ▼ |
| Ciprofloxain/dexameth | 10 | 50 | £57 | -67.4% ▼ |
| Emulsifying wax | 10 | 9,500 | £67 | -17.9% ▼ |
| Fluocinolone acetonide | 10 | 480 | £77 | -8.2% ▼ |
| 10 | 115 | £161 | -8.7% ▼ | |
| 10 | 200 | £346 | +66.4% ▲ | |
| 10 | 200 | £612 | -34.8% ▼ | |
| 10 | 38 | £748 | -27.6% ▼ | |
| 10 | 28 | £383 | +40.4% ▲ | |
| 10 | 602 | £85 | -87.6% ▼ | |
| Olmesartan medoxomil/amlodipine | 11 | 308 | £177 | -16.6% ▼ |
| Gemfibrozil | 11 | 308 | £174 | +8.9% ▲ |
| Zonisamide | 11 | 616 | £267 | -74.8% ▼ |
| Ethosuximide | 11 | 1,540 | £3.1K | -25.4% ▼ |
| Midazolam maleate | 11 | 22 | £986 | +128.0% ▲ |
| Orphenadrine hydrochloride | 11 | 13.2K | £12.2K | -4.7% ▼ |
| Calcium folinate | 11 | 330 | £943 | +40.0% ▲ |
| Potassium chloride | 11 | 220 | £22 | -41.2% ▼ |
| Tube feed additive 0.5 kcal/ml high fibre liquid (0914052) | 11 | 9,757 | £343 | +14.1% ▲ |
| Gentamicin sulfate | 11 | 110 | £204 | +100.2% ▲ |
| Loteprednol etabonate | 11 | 55 | £54 | +18.9% ▲ |
| Atropine sulfate | 11 | 160 | £730 | -13.7% ▼ |
| Calamine | 11 | 1,900 | £40 | +45.1% ▲ |
| Fludroxycortide | 11 | 71 | £265 | +4.3% ▲ |
| 11 | 1,751 | £63 | -14.7% ▼ | |
| 11 | 1,020 | £1.9K | +26.8% ▲ | |
| Methyldopa | 12 | 1,344 | £327 | -29.5% ▼ |
| INR blood testing reagents | 12 | 288 | £814 | +59.3% ▲ |
| Dabigatran etexilate | 12 | 720 | £507 | -76.8% ▼ |
| Insulin glulisine | 12 | 125 | £708 | -44.0% ▼ |
| Bromocriptine | 12 | 360 | £737 | +80.9% ▲ |
| Triptorelin acetate | 12 | 12 | £736 | -16.3% ▼ |
| Imiquimod | 12 | 348 | £1.4K | +68.9% ▲ |
| Hepatitis B | 12 | 12 | £139 | +13.4% ▲ |
| 12 | 2,160 | £3.2K | +22.7% ▲ | |
| 12 | 1,080 | £1.8K | -43.3% ▼ | |
| 12 | 220 | £103 | -46.3% ▼ | |
| 12 | 112 | £121 | -11.7% ▼ | |
| 12 | 560 | £410 | -9.6% ▼ | |
| 12 | 560 | £396 | -63.7% ▼ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 13 | 364 | £42 | -62.6% ▼ |
| Celiprolol hydrochloride | 13 | 364 | £243 | -1.7% vs avg |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.